TXA Nebulization for the Treatment of Hemoptysis
Launched by POST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH · Dec 11, 2022
Trial Information
Current as of January 22, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial is studying the use of a medication called tranexamic acid (TXA) delivered through a nebulizer to help treat hemoptysis, which is when a person coughs up blood. The goal is to see if nebulized TXA can reduce how often and how much blood is coughed up, as well as to evaluate its safety in patients experiencing this condition. The trial is currently recruiting participants who are at least 18 years old and have active hemoptysis, regardless of gender. However, individuals with severe bleeding, certain medical conditions like kidney failure, or those who are pregnant are not eligible to participate.
Participants in this study can expect to receive the nebulized TXA treatment and will be monitored for its effectiveness and any potential side effects. This trial aims to gather more information about the benefits and safety of using TXA in this new way, as there is still limited research on this approach. Your involvement could contribute to better treatment options for people with hemoptysis in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All cases of active hemoptysis
- • irrespective of gender
- • age≥ 18 years
- Exclusion Criteria:
- • Massive hemoptysis
- • Pregnancy
- • Drug allergy to TXA4
- • Renal failure
- • Receiving Oral Contraceptive Pills.
- • Already on blood thinner
- • Not willing for consent.
About Post Graduate Institute Of Medical Education And Research, Chandigarh
The Post Graduate Institute of Medical Education and Research (PGIMER) in Chandigarh is a premier institute dedicated to advancing medical education, research, and healthcare delivery in India. Renowned for its commitment to excellence, PGIMER plays a pivotal role in conducting cutting-edge clinical trials that contribute to the development of innovative therapies and improve patient outcomes. With a multidisciplinary approach and a team of highly qualified professionals, PGIMER fosters a collaborative environment for research, aiming to enhance medical knowledge and practice through rigorous scientific inquiry and evidence-based solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chandigarh, , India
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials